Company Overview

Decibel Cannabis Company Inc. is a Canadian cannabis producer focused on the cultivation, processing, manufacturing, and sale of recreational cannabis products. The company operates within the legal cannabis industry in Canada and participates primarily in branded consumer packaged cannabis products, with additional exposure to extraction and manufacturing activities. Decibel’s core revenue drivers include premium inhalable cannabis products such as dried flower, pre-rolls, vapes, concentrates, and infused products sold through provincially regulated retail distribution channels.

The company’s primary brands include Qwest, General Admission, and Voxel, which target different consumer segments ranging from premium flower consumers to value-oriented and high-volume recreational users. Decibel has positioned itself as a brand-focused cannabis operator emphasizing product quality, terpene-rich genetics, and innovation in inhalable products. The company traces its origins to the Canadian cannabis legalization wave and expanded through acquisitions and facility development, including the integration of cultivation and extraction capabilities intended to support vertically integrated operations.

Business Operations

Decibel generates revenue primarily through the production and sale of branded recreational cannabis products across Canada. Its operations include cultivation, extraction, product manufacturing, packaging, and distribution. The company’s principal operating assets include the Thunderchild Cultivation Facility in Saskatchewan, known for indoor cannabis cultivation, and the Calgary Processing Facility in Alberta, which supports extraction, manufacturing, and product development. Decibel’s business model emphasizes branded product sales through provincial wholesalers and licensed retailers rather than wholesale bulk cannabis sales.

The company operates mainly within Canada but distributes products across multiple provincial markets, including Ontario, Alberta, British Columbia, and other regulated jurisdictions. Decibel controls proprietary cultivation genetics, extraction processes, and manufacturing infrastructure used to support product consistency and innovation. Historical strategic transactions included the acquisition of AgMedica Bioscience Ltd., which expanded production and processing capacity. The company has also maintained relationships with provincial distributors and retail channels essential to market access in Canada’s regulated cannabis framework.

Strategic Position & Investments

Decibel’s strategic direction has centered on scaling branded cannabis products while improving operational efficiency and profitability. The company has focused particularly on high-growth inhalable categories such as vape cartridges, infused pre-rolls, concentrates, and premium flower products. Management has emphasized margin expansion through automation, facility optimization, and stronger brand penetration within Canada’s recreational market. The company has also pursued product innovation using terpene-focused formulations and differentiated strain offerings.

Key investments have included cultivation infrastructure, extraction technology, and manufacturing capabilities designed to support vertically integrated operations. The acquisition of AgMedica Bioscience Ltd. materially expanded Decibel’s processing and production footprint and enhanced extraction capabilities. Decibel’s portfolio strategy relies heavily on strengthening the market position of General Admission and Qwest, both of which have gained recognition within Canadian retail cannabis channels. While the company continues to monitor emerging cannabis formats and consumer trends, publicly available sources do not confirm material operational exposure outside the Canadian regulated cannabis market. Data inconclusive based on available public sources regarding significant non-Canadian expansion initiatives.

Geographic Footprint

Decibel Cannabis Company Inc. is headquartered in Calgary, Alberta, Canada, and its operations are concentrated within the Canadian legal cannabis market. The company maintains cultivation and manufacturing infrastructure primarily in Alberta and Saskatchewan, while distributing products nationally through provincial cannabis boards and authorized retail systems. Its products are available across several major Canadian provinces, including Ontario, British Columbia, Alberta, and Quebec, subject to provincial listing approvals.

The company’s operational influence remains predominantly domestic, reflecting the regulatory structure of the cannabis industry in Canada. Decibel has not established a major disclosed operating footprint outside Canada based on available public filings and company disclosures. International exposure appears limited relative to larger multinational cannabis operators, though the company monitors broader industry developments and evolving regulatory opportunities.

Leadership & Governance

Decibel’s leadership team has focused on operational execution, disciplined capital allocation, and brand-led growth within the competitive Canadian cannabis market. Governance and strategic oversight are guided through executive leadership and the company’s board structure, with emphasis on improving profitability, expanding branded product share, and maintaining compliance with Canadian cannabis regulations. The company has publicly emphasized premium product quality, consumer-focused innovation, and operational efficiency as central elements of its strategic philosophy.

Key executives include:

• Benjamin Sze – Chief Executive Officer
• Benjamin Sze – Interim Chief Financial Officer (during certain reported periods based on public disclosures)
• Paul Wilson – Founder and Former Chief Executive Officer
• Cameron Wickham – Chief Operating Officer (reported in prior company disclosures)

Executive roles and leadership composition have changed periodically as part of broader operational restructuring and strategic realignment efforts. Certain leadership appointments and role timelines vary across public disclosures and reporting periods.